300404 博濟醫藥
按盤價 
10.660 +0.010 (+0.094%)
10.660 +0.010 (+0.094%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.573 | 3.051 | 2.983 | 2.688 | 3.316 |
| 總資產報酬率 ROA (%) | 0.997 | 1.980 | 1.999 | 1.807 | 2.302 |
| 投入資產回報率 ROIC (%) | 1.235 | 2.404 | 2.335 | 2.072 | 2.629 | 邊際利潤分析 |
| 銷售毛利率 (%) | 28.451 | 27.125 | 30.375 | 33.336 | 37.932 |
| 營業利潤率 (%) | 8.941 | 3.601 | 2.505 | 3.173 | 4.611 |
| 息稅前利潤/營業總收入 (%) | 9.037 | 3.573 | 2.625 | 3.095 | 5.596 |
| 淨利潤/營業總收入 (%) | 7.299 | 3.789 | 4.132 | 4.892 | 6.918 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 117.873 | 153.067 | 164.956 | 97.999 | 102.612 |
| 價值變動淨收益/利潤總額(%) | 6.516 | 7.720 | 16.494 | 15.797 | 15.275 |
| 營業外收支淨額/利潤總額(%) | -0.024 | -4.081 | -0.908 | -0.052 | 20.496 | 償債能力分析 |
| 流動比率 (X) | 1.924 | 1.829 | 1.963 | 2.280 | 2.336 |
| 速動比率 (X) | 1.474 | 1.395 | 1.486 | 1.723 | 1.775 |
| 資產負債率 (%) | 34.063 | 34.974 | 30.942 | 31.410 | 29.769 |
| 帶息債務/全部投入資本 (%) | 19.949 | 21.519 | 19.069 | 22.019 | 20.436 |
| 股東權益/帶息債務 (%) | 397.478 | 361.254 | 419.210 | 348.080 | 379.442 |
| 股東權益/負債合計 (%) | 187.629 | 179.912 | 216.867 | 212.970 | 226.979 |
| 利息保障倍數 (X) | 91.990 | 31.556 | 18.448 | -40.563 | -27.485 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 80.440 | 74.025 | 68.922 | 66.687 | 69.345 |
| 存貨周轉天數 (天) | 132.526 | 118.722 | 135.379 | 178.493 | 216.752 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 15/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
